Price T Rowe Associates Inc Novo Nordisk A S Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Price T Rowe Associates Inc holds 8,589,222 shares of NVO stock, worth $1.16 Billion. This represents 0.14% of its overall portfolio holdings.
Number of Shares
8,589,222
Previous 7,766,186
10.6%
Holding current value
$1.16 Billion
Previous $803 Million
37.27%
% of portfolio
0.14%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding NVO
# of Institutions
1,851Shares Held
309MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$2.85 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.86 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.77 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.62 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.6 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $305B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...